Telix Pharmaceuticals Limited (TLPPF)
OTCMKTS · Delayed Price · Currency is USD
8.06
+0.38 (4.95%)
At close: Dec 26, 2025
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $2.7 billion as of December 26, 2025. Its market cap has decreased by -47.54% in one year.
Market Cap
2.70B
Enterprise Value
2.92B
Revenue
664.23M
Ranking
n/a
PE Ratio
249.18
Stock Price
$8.06
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 115.28M to 2.70B, an increase of 2,244.12%. That is a compound annual growth rate of 47.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 2.70B | -46.99% |
| Dec 31, 2024 | 5.10B | 129.18% |
| Dec 29, 2023 | 2.22B | 42.30% |
| Dec 30, 2022 | 1.56B | -2.70% |
| Dec 31, 2021 | 1.61B | 96.45% |
| Dec 31, 2020 | 817.72M | 196.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 724.00M |
| Elite Pharmaceuticals | 520.52M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 376.54M |
| CytoDyn | 353.44M |
| Nika Pharmaceuticals | 291.10M |
| Silence Therapeutics | 290.02M |